SARAJEVO (Bosnia and Herzegovina), June 27 (SeeNews) – Bosnia’s Sarajevo blue-chip index SASX-10 slumped this week due to a 21.3% collapse of drug maker Bosnalijek caused by a planned capital hike expected to be endorsed by the company’s shareholders on Saturday.